Abstract Conus medullaris/cauda equina injuries typically result in loss of bladder, bowel, and sexual functions, partly as a consequence of autonomic and motor neuron death. To mimic these injuries, we previously developed a rodent lumbosacral ventral root avulsion (VRA) injury model, where both autonomic and motor neurons progressively die over several weeks. Here, we investigate whether minocycline, an antibiotic with putative neuroprotective eVects, may rescue degenerating autonomic and motor neurons after VRA injury. Adult female rats underwent lumbosacral VRA injuries followed by a 2-week treatment with either minocycline or vehicle injected intraperitoneally. The sacral segment of the spinal cord was studied immunohistochemically using choline acetyltransferase (ChAT) and activated caspase-3 at 4 weeks post-operatively. Minocycline increased the survival of motoneurons but not preganglionic parasympathetic neurons (PPNs). Further investigations demonstrated that a larger proportion of motoneurons expressed activated caspase-3 compared to PPNs after VRA injury and indicated an association with minocycline's diVerential neuroprotective eVect. Our Wndings suggest that minocycline may protect degenerating motoneurons and expand the therapeutic window of opportunity for surgical repair of proximal root lesions aVecting spinal motoneurons.
Introduction
Conus medullaris/cauda equina injuries represent approximately 20% of all traumatic spinal cord injuries and result in paraparesis, sensory disturbance, pain, as well as autonomic dysfunction (Maynard et al. 1997; . Injuries to the conus medullaris/cauda equina commonly occur from motor vehicle accidents and include lesions to the lumbosacral roots, which may be avulsed or separated from the spinal cord (Chin and Chew 1997) . In adult rodent models, ventral root avulsion (VRA) injuries result in progressive retrograde death of motoneurons (Koliatsos et al. 1994; Novikov et al. 1995) and autonomic neurons (Hoang et al. 2003) . As a repair strategy, surgical re-implantation of the avulsed ventral roots into the spinal cord leads to functional re-innervation of skeletal muscles (Carlstedt et al. 1986; Cullheim et al. 1989 ) and the lower urinary tract . Root re-implantation procedures have been successfully performed in humans with traumatic brachial plexus injuries (Carlstedt et al. 2000) , but functional improvement is compromised with prolonged lengths of time between the injury and root re-implantation (Carlstedt et al. 2000) . This dismal outcome may be explained, in part, by the progressive VRA-induced motoneuron death. Therefore, early neuroprotection is much needed to lengthen the therapeutic window and thereby also augment functional outcome for this otherwise promising repair strategy.
Minocycline, a tetracycline antibiotic, recently emerged as a potentially attractive neuroprotective agent in animal models of stroke (Yrjanheikki et al. 1998) , spinal cord injury (Stirling et al. 2004; Teng et al. 2004) , as well as neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Huntington's disease, and Parkinson's disease (Blum et al. 2004) . Minocycline may also attenuate the development of hyperesthesia and allodynia after an L5 spinal nerve transection injury in the rat (Raghavendra et al. 2003) . The latter Wnding is of special interest to the present studies, as both transection and avulsion injuries of ventral roots may result in persistent neuropathic pain Bigbee et al. 2007 ). However, in some studies, minocycline treatment has failed to demonstrate beneWcial eVects (Smith et al. 2003; Fernandez-Gomez et al. 2005) . Although its mechanisms of action are not fully understood, some studies suggest that minocycline may prevent cell death by suppressing the apoptotic pathway (Stirling et al. 2005) . Minocycline may also inXuence non-apoptotic responses to nerve injury. For instance, minocycline has been reported to reduce the activation of microglia after a peripheral nerve injury, in part, by inhibiting the expression of p38 mitogen-activated protein kinase (MAPK) (Piao et al. 2006) . Minocycline may reduce the production of pronerve growth factor in microglia and thereby reduce death of oligodendrocytes after a traumatic spinal cord injury (Yune et al. 2007 ). Here, we examined whether minocycline may protect preganglionic parasympathetic neurons (PPNs) and motoneurons from retrograde cell death following a lumbosacral VRA injury.
Methods
All animal procedures were carried out according to the standards established by the National Institutes of Health (NIH) Guide for Care and Use of Laboratory Animals (NIH Publications no. 80-23, revised 1996) . The experimental protocols were approved by the Chancellor's Animal Research Committee at UCLA. All animals were housed in a room with a 12/12 h light/dark cycle, and they had access to food and water ad libitum. Fourteen adult female Sprague-Dawley rats (175-225 g; Charles River Laboratories, Raleigh, NC) were divided into two groups: minocycline (n = 7) and vehicle (n = 7) treatment groups.
All animals underwent a unilateral L5-S2 VRA injury, as previously described in detail (Hoang et al. 2003; . BrieXy, under gas anesthesia with 2-2.5% isoXurane (Abbott Laboratories, North Chicago, IL), a unilateral lumbar laminectomy was performed. As PPNs are located in the L6 and mostly S1 segments in the adult rat (Hoang et al. 2003) , the lesion included the neighboring roots as well. Under a surgical microscope, the left four (L5, L6, S1, and S2) ventral roots were avulsed from the surface of the spinal cord. A thin sheet of gel foam was Wrst placed over the exposed site followed by the placement of a titanium mesh cage to stabilize the vertebral column and to protect the spinal cord from compression by the overlying muscles and soft tissues (Nieto et al. 2005) . The paraspinous muscles and skin were subsequently sutured in layers, and all animals were allowed to recover. All animals maintained bladder and bowel continence during the entire study.
Minocycline (Sigma, St Louis, MO; 50 mg/kg) or vehicle (saline) injections were administered intraperitoneally (i.p.) daily for 7 days post-operatively. The Wrst dose was given on the day of surgery in connection with the root injury procedure. The minocycline dose was decreased in half (25 mg/kg i.p. daily) for days 8-14 post-operatively, providing a total of 2 weeks of treatment. This treatment duration was chosen in attempts to maximize minocycline's neuroprotective eVects during the time period with the largest degree of neuronal degeneration and death after a lumbosacral VRA injury (Hoang et al. 2003) . The solution containing minocycline was titrated to achieve a near normal pH before its i.p. administration in attempts to reduce the risk of treatment associated side eVects, especially chemical irritation at the abdominal injection site. The above protocol for minocycline administration was tolerated well by the rats in the experimental series.
At 4 weeks post-op, under deep anesthesia, the rats were intravascularly perfused with 100 ml of phosphate buVer followed by 500 ml of 4% paraformaldehyde (4°C). A close inspection of the spinal cords was performed under a dissection light microscope to conWrm the accuracy and completeness of the multilevel avulsion of ventral roots. The lumbosacral spinal cord segments were removed and postWxed overnight in the perfusion Wxative (4°C), cryoprotected in 30% sucrose in phosphate-buVered saline (PBS), frozen, and serially sectioned (40 m thick) in the transverse plane.
Every alternating second spinal cord section of the S1 segment was used for immunohistochemical detection of choline acetyltransferase (ChAT) to identify PPNs and motoneurons or double Xuorescent labeling of ChAT and activated caspase-3 to identify neurons undergoing apoptosis. For light stable immunohistochemistry, sections were placed in 0.3% H 2 0 2 for 10 min, rinsed in PBS, and incubated in 5% normal horse serum for 1 h. The sections were then incubated overnight with anti-goat ChAT (1:200; Chemicon, Temecula, CA) in 0.3% Triton X-100/PBS at room temperature. This primary antibody for ChAT detection was originally raised against human antigens but crossreacts with rat antigens. The sections were next rinsed, incubated in solution containing a biotinylated secondary antibody (1:200; Vector Laboratories, Burlingame, CA) for 1 h, rinsed, incubated with avidin-biotin complex (1:100; Vectastain ABC Elite kit, Vector Laboratories), and visualized using diaminobenzidine (DAB; Sigma). For double immunoXuorescence, sections were incubated in ChAT and anti-rabbit activated caspase-3 (1:100 Cell Signaling, Danvers, MA) overnight at room temperature, rinsed, and incubated in anti-rabbit Alexa 594 red and antigoat Alexa 488 green conjugated secondary antibodies (1:500; Molecular Probes, Eugene, OR) for 1 h at room temperature. Images were captured with a Spot digital camera (Diagnostic Instruments, Sterling Heights, MI) attached to a Nikon E600 light microscope equipped with Xuorescent excitation Wlter sets.
We used the physical dissector method for obtaining stereological counts of ChAT-immunolabeled PPNs and motoneurons (Coggeshall and Lekan 1996; West 1999 ) and in accordance with our previous studies on neuronal loss after VRA injuries (Hoang et al. 2003) . For this purpose, 10 sections from the S1 spinal cord segment in each animal were analyzed. A blinded observer counted all neuronal proWles except for neurons with cell bodies that were bisected at the rostral surface of each 40 m section. The cell count was expressed as a ratio of the number of neurons on the avulsed side divided by the number of neurons on the contralateral, non-lesioned side. To obtain the percentage of surviving PPNs and motoneurons that expressed activated caspase-3, a minimum of six sections per animal were analyzed in the light microscope by two observers. The two independent counts were in agreement and averaged.
Statistical analyzes were performed using the non-parametric Mann-Whitney (two-tailed) test (SigmaStat 3.1, Systat Software Inc., Point Richmond, CA). We regarded P < 0.05 as reXecting a statistically signiWcant diVerence between samples. Quantitative data were expressed as mean § standard error.
Results
We Wrst performed a quantitative analysis on the eVect of a lumbosacral VRA injury on the axotomized PPNs and motoneurons in the S1 spinal cord segment. The PPNs normally innervate autonomic pelvic ganglia (de Groat and Yoshimura 2006), whereas the S1 motoneurons innervate, e.g., the musculus levator ani of the pelvic Xoor and tail muscles (Schrøder 1980; Grossman et al. 1982 ). We here demonstrate that the degree of cell survival for PPNs (48 § 7%) was signiWcantly greater than that of motoneurons (16 § 3%; P < 0.05; Fig. 1, Table 1 ) at 4 weeks post-VRA. One possible contributing explanation for this diVerence in cell death between the studied neuronal types is that motoneuron somata of the S1 segment are located approximately 300-500 m from the avulsion injury site at ventral root exit zone, whereas PPN somata are located approximately 1,200-1,400 m from the lesion site. This anatomical aspect may be relevant, as previous studies have demonstrated that neuronal responses to injury may be dependent, in part, on the distance between the axotomy site and the cell body (Lieberman 1971; Herdegen et al. 1997) .
We also assessed the potential eVects of minocycline treatment on the survival of axotomized PPNs and Note that signiWcantly more PPNs survived than motoneurons after injury in the vehicle group. Scale bar 60 m and applies to all high magniWcation images motoneurons after the VRA injury. Interestingly, when compared to the retrograde response observed in our above injured control group, rats in the minocycline treatment group (n = 7) showed a signiWcantly increased survival for motoneurons (33 § 6%; P < 0.05), but not for PPNs (45 § 5%; Fig. 1c) .
We next examined the expression of activated caspase-3, a marker for the Wnal common pathway of apoptosis, to determine whether speciWc mechanisms of cell death may be associated with the diVerential neuroprotective eVect provided by minocycline on the axotomized motoneurons and PPNs (Fig. 2) . Here, the neuropil of both the lesioned and treatment groups demonstrate immunoreactivity for activated caspase-3 in a subpopulation of glial nuclei. In addition, subpopulations of both motoneurons and PPNs expressed immunoreactivity for the activated caspase-3 in the injured vehicle group and the minocycline treatment group. However, activated caspase-3 was only detected in PPNs and motoneurons on the side ipsilateral to the root injury, with absence of any neuronal localization for activated caspase-3 on the non-lesioned contralateral side of the spinal cord. Quantitative studies showed that there was a signiWcantly larger percentage of activated caspase-3 labeled motoneurons (37 § 4%) than PPNs (10 § 2%) on the lesioned side in the vehicle group (n = 7; P < 0.05) ( Table 2) . It is here interesting to note that the more pronounced loss of motoneurons than PPNs in our sample is also associated with a higher percentage of motoneurons expressing the activated caspase-3. In the minocycline group (n = 7), this diVerential expression of activated caspase-3 was also maintained between motoneurons (28 § 4%) and PPNs (9 § 3%) ( Table 2) . Thus, although the minocycline treatment increased the overall number of surviving motoneurons, the portion of surviving motoneurons showing expression of the activated caspase-3 remained elevated in the treatment group.
Discussion
Our results demonstrate that minocycline doubled the number of surviving motoneurons, but had no eVect on PPNs despite the fact that the two groups of neurons suVered the same trauma. Our further investigations demonstrated a diVerential expression of activated caspase-3 after VRA injury, which suggests a fundamental diVerence in death mechanisms between motoneurons and PPNs, perhaps explaining in part why minocycline protected motoneurons but not PPNs.
Minocycline-mediated neuroprotection may be associated with, e.g., inhibition of p38 MAPK activation in microglia or with prevention of apoptosis by the inhibition of caspase activation (Stirling et al. 2005) . Activated caspase-3 in the spinal cord milieu is reduced by minocycline during the Wrst 24-72 h after a mid-thoracic spinal cord injury and is associated with functional improvement and spinal cord tissue sparing up to 4 weeks after injury (Lee et al. 2003; FestoV et al. 2006) . In our study, we examined the expression of activated caspase-3 following a 2-week treatment to determine whether minocycline may have a sustained inXuence on neuronal fate at 4 weeks post-VRA. Although minocycline increased motoneuron survival, the percentage of motoneurons expressing activated caspase-3 did not diVer between the experimental groups, raising the possibility that minocycline may only delay motoneuron death. The neuroprotection of motoneurons in this study shares some resemblance with the eVect of minocycline in delaying the onset and halting the progression of motoneuron death in murine ALS models (Zhu et al. 2002) , which may be mediated by apoptosis as well (Przedborski 2004) . However, degenerative motoneuron conditions in the human are associated with a diVerential vulnerability between subsets of motoneurons. Although the bladder and anal sphincter functions typically remain intact in ALS, reports have demonstrated that motoneurons of Onuf's nucleus may also be vulnerable to a degenerative process but to a lesser degree than other somatic motoneurons (Kihira et al. 1997) . A diVerential expression of glutamate receptors between motoneurons of Onuf's nucleus and other somatic motoneurons has been suggested to oVer a clue to the selective vulnerability patterns in ALS (Anneser et al. 2004) . Therefore, it is noteworthy to clarify that the motoneurons of the S1 segment in the present study likely innervate the pelvic Xoor and tail muscles (Schrøder 1980; Grossman et al. 1982 ) but do not include the external urethral and anal sphincter-innervating motoneurons of the Onuf's nucleus homolog in the rat L6 spinal cord segment. The mechanisms underlying the VRA injury-induced motoneuron death remain controversial, as studies have shown support for both apoptosis and necrosis. Evidence of apoptosis after nerve avulsion injuries include activation of caspase-3, fragmentation of nuclear DNA, nuclear accumulation of p53, and translocation of Bax from the cytoplasm into mitochondria (Martin and Liu 2002) . In addition, genedeWcient Bax ¡/¡ and p53 ¡/¡ mice demonstrated absence of motoneuron death (Martin and Liu 2002) . Despite the abundant evidence for apoptosis, treatment attempts with caspase inhibitors failed to rescue motoneurons after a cervical VRA injury (Chan et al. 2001) . In addition, axotomized motoneurons demonstrated ultrastructural features typical of necrotic cell death, including perturbation, disruption and depletion of cytoplasmic organelles (Li et al. 1998) . Furthermore, the lytic membrane attack complex, which leads to necrotic cell death, was increased on the surface and around injured motoneurons, and Clusterin expression was upregulated as a defense mechanism against the complement attack in motoneurons after VRA injury (Ohlsson and Havton 2006) . While the above studies altogether suggest that both apoptosis and necrosis contribute to VRA-induced motoneuron death, the mechanisms as to the concurrent autonomic neuron death are less well understood. Our Wnding suggests that PPNs do not undergo apoptosis to the same extent as motoneurons after VRA injury, thus diVerent strategies may be needed to protect autonomic neurons. When using ChAT as a marker for motoneuron or PPN detection in quantitative studies, it is important to take into consideration potential axotomy-induced eVects on protein expression. SpeciWcally, the expression of ChAT may be decreased in motoneurons following injury to their axons (Lams et al. 1988; Kou et al. 1995; Bussmann and Sofroniew 1999) . However, the axotomy-induced decrease in the expression of ChAT in motoneurons and PPNs following an injury to their axons is temporary, as ChAT immunoreactivity gradually returns to detectable levels over time with all axotomized motor and autonomic neurons being detectable by ChAT immunohistochemistry by 4 weeks after the injury (Rende et al. 1995; Hoang et al. 2003) . In the present study, we investigated the neuronal counts at 4 weeks after the VRA injury. Therefore, the present neuronal counts should reXect an accurate assessment of surviving ChAT-immunoreactive neurons.
Here, we demonstrated immunoreactivity for caspase-3 in a subpopulation of glial nuclei. This Wnding is consistent with previous reports on the spinal cord gray matter of rats in control series and after ventral root lesions (Martin and Liu 2002; Hoang et al. 2003) . It was recently identiWed that a subpopulation of astrocytic nuclei normally expresses activated caspase-3 throughout the central nervous system, and that this expression pattern is related to a yet to be deWned non-apoptotic function (Noyan-Ashraf et al. 2005) .
Minocycline is currently being investigated clinically as a potential treatment for a variety of neurological conditions (Blum et al. 2004; Huntington Study Group 2004) . We postulate that minocycline may also be beneWcial if combined with root re-implantation surgeries to protect motoneurons against retrograde death, expand the window for surgery, and thus promote improved functional recovery after proximal nerve avulsion injuries. For instance, minocycline may act to partially enhance the function of the lower urinary tract when combined with implantation of lesioned lumbosacral roots into the conus medullaris, as we recently demonstrated a positive correlation between voiding eYciency and motoneuron survival in the adult rat after VRA injury and repair .
